Physicochemical Compatibility of Propofol-Lidocaine Mixture

Anesthesia and Analgesia

Volumn 97, Issue 6, 2003, Pages 1646-1651

  Masaki, Yoko ^a   Tanaka, Makoto ^a   Nishikawa, Toshiaki ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; OIL; PROPOFOL;

ARTICLE; COLOR; DRUG MIXTURE; EMULSION; GAS CHROMATOGRAPHY; LUNG EMBOLISM; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

EID: 0345283348     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000087802.50796.FB     Document Type: Article

References (21)

1. Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia 1998;53:468-76.
2. Macpherson RD. Pharmaceutics for the anaesthetist. Anaesthesia 2001;56:965-79.
3. Doenicke AW, Roizen MF, Rau J, et al. Reducing pain during propofol injection: the role of the solvent. Anesth Analg 1996; 82:472-4.
4. Lilley EMM, Isert PR, Carasso ML, Kennedy RA. The effect of the addition of lignocaine on propofol emulsion stability. Anaesthesia 1996;51:815-8.
5. Masaki Y, Tanaka M, Nishikawa T. Changes in propofol concentration in a propofol-lidocaine 9:1 volume mixture. Anesth Analg 2000;90:989-92.
6. Eriksson M, Englesson S, Niklasson F, Hartvig P. Effects of lignocaine and pH on propofol-induced pain. Br J Anaesth 1997;78:502-6.
7. Washington C. The stability of intravenous fat emulsions in total parenteral nutrition mixtures. Int J Pharm 1990;66:1-21.
8. Driscoll DF, Bhargava HN, Li L, et al. Physicochemical stability of total nutrient admixtures. Am J Health Syst Pharm 1995;52: 623-34.
9. Yu HY, Liau JK. Quantitation of propofol in plasma by capillary gas chromatography. J Chromatogr 1993;615:77-81.
10. Fan SZ, Yu HY, Chen YL, et al. Propofol concentration monitoring in plasma or whole blood by gas chromatography and high-performance liquid chromatography. Anesth Analg 1995; 81:175-8.
11. Tanimura H, Miki K, Hikasa Y. Scanning electron microscopic study of intravenous fat emulsions. Nippon Geka Hokan 1979; 48:439-49.
12. Babl J, Doelxicke A, Mönch V. New formulation of propofol in an LCT/MCT emulsion: approach to reduce pain on injection. Eur Hosp Pharm 1995;1:15-21.
13. Illum L, Davis SS, Wilson CG, et al. Blood clearance and organ deposition of intravenously administered colloidal particles: the effects of particle size, nature and shape. Int J Pharm 1982;12: 135-46.
14. 141Ce labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. J Pharm Sci 1980;69:755-62.
15. Han J, Davis SS, Washington C. Physical properties and stability of two emulsion formations of propofol. Int J Pharm 2001;215: 207-20.
16. Gajraj NM, Nathanson MH. Preventing pain during injection of propofol: the optimal dose of lidocaine. J Clin Anesth 1996;8: 575-7.
17. Vidovich MI, Peterson LR, Wong HY. The effect of lidocaine on bacterial growth in propofol. Anesth Analg 1999;88:936-8.
18. Wachowski I, Jolly DT, Hrazdil J, et al. The growth of microorganisms in propofol and mixtures of propofol and lidocaine. Anesth Analg 1999;88:209-12.
19. Sherry E. Admixture of propofol and alfentanil: use for intravenous sedation and analgesia during transvaginal oocyte retrieval. Anaesthesia 1992;47:477-9.
20. Wilson RJT, Ridley SA. The use of propofol and alfentanil by infusion in military anaesthesia. Anaesthesia 1992;47:231-3.
21. Rau J, Roizen MF, Doenicke AW, et al. Propofol in an emulsion of long- and medium-chain triglycerides: the effect on pain. Anesth Analg 2001;93:382-4.